Skip to content

Category Archives: Terumo Corporation

Terumo Corporation > Expands Glidewire Hydrophilic Coated Guidewire Product Line > 11 new guidewire configurations > Bolia curve > New tip shape design > Therapeutic intervention in previously unreachable vascular beds

Friday, February 15, 2008

Will the additions to the Hydrophilic Coated Guidewire line assure that the procedures become easier and more efficient? Will the the unique 1 cm taper that is available in different lengths and stiffness make therapeutic intervention possible in previously unreachable vascular beds? Will the new line enable Terumo to repeat the success of having […]

Filed in Vascular Surgeons, Interventional Cardiologists, Interventional Neuroradiologists, Transfusion medicine, Glidewire Hydrophilic Coated Guidewire, Difficult-to-reach lesions, Aman Bolia, Bolia curve, Interventional Radiologists, Interventional procedures, NOBORI drug-eluting stent system, Terumo Corporation, Medical Device Company, Terumo Corporation, Needles and syringes, Tokyo-based, Sterile connection device, Entry-site management products, Endoluminal Endolumenal Hollow Vessel | Comments (0)

Biosensors International Group > Receives CE Mark Approval for its BioMatrix Drug-Eluting Coronary Stent System > BioMatrix and NOBORI drug-eluting stents > Stents incorporate a biodegradable polymer coating together with an immunosuppressive drug

Saturday, January 19, 2008

Will BioMatrix provide a valuable alternative to the drug-eluting stents currently available to interventional cardiologists? Is the three-year follow-up data released at the Transcatheter Cardiovascular Therapeutics Conference showing BioMatrix’s superior results in terms of safety and clinical effectiveness? Will the increasing complexity of worldwide regulatory requirements make it more difficult in the future to introduce […]

Filed in PLA polymer fully degrades into water and carbon dioxid, Leaving in place a biocompatible stent surface, Drug has a higher lipophilic and hydrophobic profile, Immunosuppressive and anti-inflammatory properties, NOBORI drug-eluting stent system, Polymer coated onto the outer abluminal side of the ste, Drug to be released to targeted tissue, Transcatheter Cardiovascular Therapeutics Conference, Siegburg Heart Center, Eberhard Grube, Three separate drug-eluting stent programs, Terumo Corporation, Biolimus A9 biodegradable polymer and advanced stent de, Biosensors International Group, Medical Device Company, Efficacy, Medical Universities Research Institutes Med Societies, BioMatrix, Axxion, BioMatrix clinical trial program, Drug eluting stents, Licensed aspects of its drug-eluting stent technology t, BioMatrixFreedom polymer-free drug-eluting stent, Endoluminal Endolumenal Hollow Vessel | Comments (0)